Korean Drug Co., Ltd. announces an Equity Buyback for 14,000 shares.
December 14, 2020 at 12:20 am EST
Share
Korean Drug Co., Ltd. (KOSDAQ:A014570) announces a share repurchase program. Under the program, the company will repurchase up to 14,000 shares. The purpose of the program is to improve stock value through stock price stabilization and payment of incentives for retirees. The program will expire on March 14, 2021. As of December 13, 2020, the company had 104,663 shares in treasury within scope available for dividend and had 0 shares in treasury through other repurchases.
KOREAN DRUG CO.,LTD is a Korea-based company engaged in the manufacture and distribution of pharmaceuticals. The Companyâs products portfolio consists of over-the-counter (OTC) medicines, ethical (ETC) medicines and health food, including multi-symptom cold medicines, blood-forming nutrients, treatments for central nervous system, remedies for respiratory diseases, dermatological agents, vitamins, antifungal agents, antipyretics, analgesics, anti-inflammatory drugs, antibiotics, allergic treatments, calcium and vitamin D tablets and home pregnancy test kits, among others.